Day Surgery
Full text
(2)
(3)
(4) . DaySurgery . Routines,painandrecovery . MethaBrattwall . . ǡʹͲͳͲ .
(5) DaySurgery____________________________________________________________________________________ ǣǡÚ . ToallmydaysurgeryfriendsandcoǦworkers.
(6) ͻͺǦͻͳǦʹͺǦͺͳͻͲǦͲ ǣȀȀǤǤȀʹͲȀʹʹͻ͵
(7)
(8) . . .
(9) ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Abstract. ABSTRACT Ǥ ǡ Ǥ Methods:IǣʹͲͲͷ ǤII,III,IVǣȋ͵ͷͷȌ ǡ ǡǦǦǡ Ǥ Ǣ ǡ ǡ Ǥ ǤͺǦǦͷǤ ǤVǣ ǡ ͳͲͲǤ Results:
(10) I Ǥ II Ǥ
(11) IIIǡ ͲȀ͵ͷͷ͵Ǥ ͶͲΨǡʹͺΨʹͲΨ ͳǡʹ Ͷ Ǥ Ǥ
(12) IV, ͺǦ ǦǤ
(13) Vǡ Ǥ Conclusions:Ǥ Ǥ Ǥ ǦǤ
(14) ǡ
(15) Ǥ Keywords:ǡǡ ǡǡ ǡ ȋȌǡ ǡǡ ǡǦͷǡ ǡǦǡǦǤ. . ͵.
(16) DaySurgery____________________________________________________________________________________. CONTENTS ABSTRACT CONTENTS LISTOFPUBLICATIONS ABBREVIATIONSANDEXPLANATIONS THESISATAGLANCE INTRODUCTION. History DSversusinǦhospitalsurgery Futureperspectives Therecoveryprocessandtoolstoassessrecovery Ǧ Guidelines StudyIǦV. 3 4 6 7 8 9. 9 10 ͳͲ 10 ͳͲ 11 ͳͳ ͳͳ 12 12. AIMS MATERIALANDMETHODS. 13 14. STUDYSUBJECTS. 17. REVIEWofRESULTS. 19. DISCUSSION. 31. StudyI: StudyIIǦIV: StudyV: Questionnaires,EQǦ5dand8Ǧitemhealthprofile: Statistics: StudyI: StudiesIIǦIV StudyV StudyI StudyIIǦIV StudyV Summary. Hypothesisandaim BackgroundandpresentstatusofDS(studyI)
(17) ǡ StudyIIǦIIIǦIVǦV Managementofpostoperativepain ǡ . Ͷ . 14 14 15 16 16. 17 18 18. 19 20 28 30 31 31 ͵ͳ ͵ʹ ͵ʹ ͵͵ ͵͵ ͵͵ ͵Ͷ ͵Ͷ ͵Ͷ ͵ͷ 35 35 ͵ͷ.
(18) ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴Contents.
(19) ǦǦ Ǧ TreatmentoflongǦlastingpain Ǧ Postoperativenauseaandvomiting RecoveryfollowǦup Ǧ
(20) ǡ Ǧ ǡ Limitations Futureperspectives. ͵ͷ ͵ͷ ͵ ͵ ͵ ͵ ͵ ͵ ͵ͺ 38 ͵ͺ ͵ͺ ͵ͻ ͵ͻ ͵ͻ 40 Ͷͳ Ͷͳ Ͷͳ 41 Ͷʹ Ͷʹ Ͷ͵ Ͷ͵ ͶͶ ͶͶ ͶͶ Ͷͷ 45 46. CONCLUSIONSandIMPLICATIONS. 48. ACKNOWLEDGEMENTS REFERENCES POPULÄRVETENSKAPLIGSAMMANFATTNING STUDIESIǦV QUESTIONNAIRES . 50 51 60. Patientselectionforprophylactictreatment Optimisedpaintreatment QualitycontrolandmethodsforfollowǦup DurationoffollowǦup Patientinformation Summary. 48 48 48 48 49 49. . . ͷ.
(21) DaySurgery____________________________________________________________________________________. LISTOFPUBLICATIONS. . . Originalstudies ǡ ǣ
(22) Ǥ ǡ±Ǧǡǡǡ Ǥ ǣǦǤ ǤʹͲͲͺ ǢͷʹȋͳȌǣͳͳǦʹͶǤ
(23)
(24) Ǥ ǡ±ǡǡǡ ǡ Ǥ ǡǡ Ǧ Ǥ ǤʹͲͳͲǢͷͶȋ͵Ȍǣ͵ʹͳǦǤ
(25)
(26)
(27) Ǥ ǡ±ǡǡǡ ǡ Ǥ Ǣ ͵Ͳ ǤǤ Ǥ ǤʹͲͳͲ Ǥ
(28) Ǥ ǡǡǡǡ ǡ Ǥ ǣǦ Ǥ ǤʹͲͳͲǢ͵ͺȋȌǣͷͶǦͻǤ Ǥ ǡ
(29) ǡ Ǥ ǣ Ǧ ǤǤʹͲͳͲǢͳͳͳȋʹȌǣͷͶͶǦͻǤ. .
(30) ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴ Abbreviations . ABBREVIATIONSANDEXPLANATIONS . . . . . . . . . ǦǦ. ǦʹǦ. Ǧ. . . . . Ǧͷ. ͷ. ͷǦ ͵Ǧ . ͷǦǦ͵Ǧ . . . . .
(31) . .
(32) . .
(33) . .
(34) Ǧ. .
(35) Ǧ. . . . . .
(36) . ǦǦ. . . . . . Ǧ . . . . Ǧ. . Ǧ. . . . . . . . .
(37) . DzÚÚ ¤dz. . . . . . .
(38) DaySurgery____________________________________________________________________________________ . THESISATAGLANCE Aim and focus. Study size 92 hospitals. Study period One year (2005). Study I. Inventory of routines in Sweden. Study II. Impact of n=390 tobacco use on PONV and pain. Until 1 week postsurgery. Study III. Recovery Readmissions Contacts Pain. n=390. Until 4 weeks after surgery. Study IV. Health profile Quality of life. n=390. Until 6 months after surgery. Study V. Choice of analgesics Coxib or Tramadol after hallux valgus. n=50 + 50 1 week 2 weeks 16 weeks. Methods Questionnaire. Results. Standardized regimes. 50% day surgery. Pain the main symptom Prospective Smoke and questionnaires snuff reduce Multi-centre PONV. Age and gender influence PONV. Pain the main Prospective questionnaires symptom. Day surgery is safe. Recovery is End-points: procedure improved specific. recovered Prospective Preoperative questionnaires profile is important. Different End-point: fully recovered follow-up times required. Etoricoxib Prospective most effective randomized and less sidedouble-blind effects. No impaired Phone and healing. visits.
(39) ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴ . Introduction. INTRODUCTION ǢǤǤ Ǥ ȋͳͺͶǦ ͳͻʹͳȌ Ǥ ǯ . ǡͻͲͲͲ ͳͻͲͻȋͳȌǤ ǡǣǡǡ ǡʹ͵ǡǡǦ Ǧ ǡȋʹȌǤ ȋ͵ȌǤ Ǥ
(40) ȋ
(41) ǡǣȀȀǦǤ ȌǤ
(42) ǡ Ǥ
(43) ǡȋȌǤ. History Ǧ Ǥ
(44) ǡ ǡ Ǥ Ǥͳͻʹ ȋȌǡȋͶȌǤ ǡ ǡͳͻͺͲƲǡ Ǥ
(45) Ǧ ǡ Ǥ
(46) Ǧǡ Ǥ ʹͲǦ͵Ͳǡ ǡ Ǥ ͳͻͻͻǤ
(47) Ǥ . . ͻ.
(48) DaySurgery____________________________________________________________________________________. DSversusinͲhospitalsurgery ǡ Ǥ Ǧ ǡ ȋͷǦȌǤ ǡ ǡ Ǥ Ǧǡ ȋǦͺȌǤ Ǥ ǡǦ ǡ Ǥ ǦȋͻȌǤ ǡ ǡ Ǥ
(49) ȋͳͲȌǤ Benefits ǡ Ǧ ȋͳͳȌǤ. Futureperspectives Ǥ
(50) ʹͲͲͺǡ ͲΨ ȋ ǡǤǤȌǤ ǡ ͷΨ ȋͳʹȌǤ ǡ Ǥ ǡǡ ǦǤ ǡ ǡ ȋͳ͵ȌǤ
(51) Ǧ Ǥ Paintreatment Ǥ
(52) ǡ Ǥ ȋͳͶȌǤ ͳͲ .
(53) ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴ . Introduction.
(54) ȋ
(55) ȌǦǡ ͷǤ ȋͳͷȌǤ Ǥ. Therecoveryprocessandtoolstoassessrecovery ǣ x. x x x. Early ǡ ȋǡǡ ȋȌǡ ǡ ȌȋͳȌǤ FasttrackǦǦ ȋȌ ȋͳȌǤ Dischargeeligibilityǡ ȀǡȋͳͺǦʹͲȌǤ Streetfit ȋʹͳȌǤ. FollowͲup ȋʹͳȌǤ Ǥ ǡ
(56) ȋ
(57) Ȍǡ Ǧ ͵Ͳ ȋǣȀȀǤǤȀ Ȁ ǤȌǤ Ǥ Healthprofile Ǥ ǡ Ǥ ǡ Ǥ Ǥ Ǥ. . ͳͳ.
(58) DaySurgery____________________________________________________________________________________. Guidelines ǡ ǤǦ Ǥ ǡ Ǧ Ǥ Ǧ ǡǡ ǡǦ Ǥ ǡ Ǥ. StudyIͲV
(59) ǡǡ ǡǤ ǡǡpostoperative course after DS (study I). ǡ ǡ ȋ
(60)
(61)
(62) Ǧ
(63) ȌǤ ǦǦ Ǥ ǡǡȋʹͲȌǤ Ǥ
(64) ǡ Ǥ ǦȋʹʹȌǤ
(65) ǡǡ ǡ Ǥǡ ȋ
(66)
(67) ȌǤ ǡ ǡ Ǥ Ǧ ȋʹ͵ǦʹͶȌǤ
(68) ǡ Ǥ Ǣ ǡ Ǥͳ ȋȌǤ ͳʹ .
(69) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Aims. AIMS Thegeneralaim: ToinvestigateroutinesofDS,painandrecoveryinDSpatientsandtoimprove knowledgeofthepostoperativecoursefordifferenttypicalDSprocedures StudyI: StudyII: ȋȌ ǡ StudyIII: ǯǦ ǡ ͵Ͳ StudyIV: Ǧ ǡ ǦǦ StudyV: ǡ Ǧǡ ǡ Ǧͷ. . ͳ͵.
(70) DaySurgery____________________________________________________________________________________. MATERIALANDMETHODS . StudyI:
(71) ʹͲͲǡͻʹ ǡ͵Ͳ ʹͲͲͷȋ ȌǤ ǡ ǡǡǦ ǡǦ ǡ ǡ ǡǡ ǡǦǡ ǡ Ǧ Ǥ ȋ ͵ ͵ Ǥʹ ȌǤ. StudyIIͲIV: Ǧ Ǧ ʹͲͲʹͲͲͺǤ͵ ǣȋ
(72) Ȍǡ ȀÚ ȋȌ Ú ȋȌǤ ǡ ȋͳȌǤ
(73) ǡ ǡǡ Ǥ ǡ ͳȋʹȌǤ Ǣʹǡ Ͷǡ͵ȋ͵Ȍǡ ǦȋͳȌǤ Ǥ ǡǦ Ǥ DzdzDzdzǡ Ǥ. ͳͶ .
(74) . . MaterialandMethods. Table 1: Time points for patient assessed questionnaires in studies II-IV. Time:. PreRecovery Day 1 operative room. 1 week. 2 weeks. 4 weeks. 3 months. 6 months. Study no: 3 4 5 Ǥ Ǣ ǡ
(75) ǡǦǦǡ ǤǦ ǡ
(76) Ǥ. StudyV: ʹ Ǥ ͳʹͲͳͶͻͲͳ ͵Ǥ ͳͲͲʹǤ Ǧ Ǥ Ǥ ǡ ͷ ǡ Ǥ Ǥͺ ǡǡ Ǥ Ǥ ȋͶȌǦ ǡ Ǥ Ǧͷ ȋͲǦͳͲͲȌ ͳǤ ͳʹǦͳǡ ǤͳʹǡǦ Ǥͳǡ Ǧͷ Ǥ . ͳͷ.
(77) DaySurgery____________________________________________________________________________________. Questionnaires,EQͲ5dand8Ͳitemhealthprofile: ͷȋͷȌ ȋʹͷȌǤ
(78) ǦǤ Ǧ ǡ ǢȀ ǡ ǡǦ ǡ ȀǤ͵ ǢǡǡǤ
(79)
(80)
(81) Ǧ
(82) ǡ ͷǦͷ ǡ Ǥ ǡȋͳǡ͵ȌǤ
(83) ǡǦͷͷ ǡȋǤǤǡͶȌǤ. Statistics: ȋȌͳͷǤͲǤ ǦǦ ǡ Ǥ
(84) ǡ ǤǦ Ǥ Ǧ ȋȌǤ
(85)
(86) ǡ Ǥ ǡ Ǥ ǡ δͲǤͲͷǤ. ͳ .
(87) . . StudySubjects. STUDYSUBJECTS StudyI: ͻʹ ¤ . . . Ú. ¤Ȃ͵. ¤. . Ȃ͵. ¡ . Ú. . Ú. . . Ú. ¤. ¡. . . ¡. . . ¡¤. Ú. Ú. ¡Ú. . . . ¤. . ". ¡. ¡. YǦͶ. ÚǦ. Ú. YÚ. . . Y. . ¤. . . ¡. ¤. ÚÚ. . . Ú. . ¤. . Ȃͳͳ. . Ú. . . . Ú¡. . . . . . ¡. ¡. ¡. . ͳ.
(88) DaySurgery____________________________________________________________________________________. StudiesIIͲIV Table2a:ThestudysubjectsinstudyII,IIIandIV:. Number allocated Number included Age (mean years) Smokers and/or snuffers Gender M/F % Hospital ASA 1 ASA 2 ASA 3 ASA 4 ASA miss. IHR 120. AS 132. CBA 138. Total 390. 107 63. 122 42. 126 27. 355 41. 29. 42. 41. 112. 82/18 Arvika 58 42 5 2. 52/48 Mölndal 91 21 4 6 -. 0/100 Falköping 114 4 8. 43/57 263 67 9 6 10. StudyV Table2b:ThestudysubjectsinstudyV. Number asked Number included Age (mean years) Smokers Gender M/F % ASA 1 ASA 2. ͳͺ . Etoricoxib 50 49 47r11 7 0/100 41 8. Tramadol 50 49 51r10 7 0/100 40 9. Total 100 98 49 14 0/100 81 17.
(89) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. REVIEWofRESULTS StudyI ͻʹǡͺͳͺͺΨǤ ǤͳͳǦ Ǥ
(90) ʹͲͲͷͷͲΨ Ǥ Ǣ͵ʹΨ
(91) ͵ͷǡͳʹΨ ͷ Ǥ Ǥ Ǥ
(92) ͳǡ Ǥ Figure1: ǡΨ 0. 10. 20. 30. 40. 50. 60. 70. 80. 90. 100. Preoperativeassessment Healthquestionnaire RiskstratificationforPONV Oralpremedication Premedicationwithanxiolytics Analgesiastartingpreoperatively Multimodalpaintreatmentregime Standardizeddischargecriteria Escortondischarge Reporttoprimaryhealthcare Writteninformationaboutsurgery Informationaboutpaintreatment TelephoneͲnumberforinformation. Ǥ Ǥ ͻͷΨǡ
(93) ͵Ψ Ǥ ε͵Ǥǡ ǡ Ǧ Ǥ Ǧ ǡ ǡ . ͳͻ.
(94) DaySurgery____________________________________________________________________________________. ͳǦ͵ ͶʹΨǤ. StudyIIͲIV
(95) ǡ͵ͻͲ ǢͳʹͲȋ
(96) Ȍǡ ͳ͵ʹ ȋȌͳ͵ͺ ȋȌ Ǥ ͵ͷ͵ͻͲ ǣ x x x x. Ǧ . ǯȋ͵Ȍ͵ Ǥ ǡ Ǧ Ǥ Table3:numbers%ȋǦͷǦǢpain, mobility,depression,selfcare,usualactivitiesȌǤ. 1. Pain trouble 2. Mobility problems 3. Depressed mood 4. Difficulties to manage self-care 5. Socially inactive outside home 6. Sleeping disturbance Headache 7. Disability to sex 8. Need of analgesics >3 times/week Sick-listed > 1week before surgery A waiting time > 3 month before surgery. ȗδͲǡͲͷǤ . ʹͲ . IHR. AS. CBA,. %. n=107 52 * 33 * 11 2 19 20 14 21 15 14 75. n=122 80 * 68 * 21 2 18 30 20 8 29 31 70. n=126 6 9 6 2 10 5 14 9 4 7 25. of all 40% 31% 11% 2% 13% 15% 15% 11% 14% 15% 48%.
(97) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. ȋȌ͵ǡ ȋʹȌ͵Ψ ε͵ ȋͶȌǤ
(98) ͳǤǡͳǤ ͵ǤǤ ǡ
(99) Ǥ ǡ ȋͷȌǤ ǡǡǤ Ǥ. Table 4: Patients in pain at different time points (%) from all included Time points PACU At discharge Day 1 1 week 2 weeks 4 weeks. IHR + AS + CBA n= 355 36 % VAS > 3 at ambulation 56 % 40 % 28 % 20 %. Nicotine-user. Non-nicotine-user. 27 % 49 %. 44 % 58 %. Ǥ ȋͷǡʹ ȌǤ ǡ Ǥ. . ʹͳ.
(100) DaySurgery____________________________________________________________________________________. Table6: ȋȌ. ʹʹ .
(101) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. Figure2a: Ȁȋ ǡ Ȍ . . ʹ͵.
(102) DaySurgery____________________________________________________________________________________. ͺǦ ǡǡ ǡ ͳͶȋ͵ȌǤ Figure3: ǡ ǡ ȋα͵ͷͷȌ. 60 50. pain mobility mood sel-care activity sleep sex analgesics. 40 30 20 10 0 preop. day 7. day 14. ǡ
(103) ǡ ʹ ȋȌǤ. ʹͶ .
(104) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. Table7: ǡͺǦ ʹ ȋȌǤ Ψ IHR 1.Pain 2.Mobility 3.Mood 4.Self-care 5.Activity 6.Sleep 7.Sex 8.Need for analgesics . AS. 49-30 Im * 29-21 Im 10-2 Im 2-0 Im 18-5 Im 19-2 Im 20-14 Im. 66-45 Im ** 56-64 W ** 17-10 Im 2-18 W 15-14 Im 25-17 Im 7-20 W. 5-42 W*** 6-37 W*** 5-6 W 2-8 W 8-4 Im 4-19 W 7-11 W. Entire cohort 40-39 Im 31-41 W 11-6 Im 2-9 W 13-8 Im 15-13 Im 11-15 W. 14-9 Im. 24-28 W. 3-32 W. 14-23 W. ͺ ͶȀͶ. CBA. ͳȀ. ͶȀͶ. Im W ȗδͲǡͲͷǡȗȗδͲǡͲͲͳǡȗȗȗδͲǡͲͲͲͳ ǦʹͶ ȋȌǡ ȋͶͷȌǤ Figure4: pain. . ʹͷ.
(105) DaySurgery____________________________________________________________________________________. Figure5: mobilityproblems. Ǧ Ǥ ǡ ȋ
(106)
(107)
(108) ȌǤ ͵Ͳ ǡ ȋͺȌǤ Ǧ͵ͲͳͻΨȋȀ͵ͷͷȌ Ǥǡ ͵ͲǤǡ ǡǡ ͵ͲǦǦǤ Table 8: Number of patients with pain at 30 days and their preoperative profile IHR Pain at 30 d Preoperative pain sign Preoperative depression sign Preop. analgesic use Preop. immobilization Female gender. ʹ . AS 12 9. p=0.2058. CBA 41 33. p=0.0075** 5. p=0.2042. 67 44. 1. 16. 1 1 14. 20 30 40. p=0.1709 10. p=0.8051 4 8 3. Total 14 2. p=0.6088 15 21 23.
(109) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. ǡǡǡǡ Ǧ ǡ ǡ ̶ ̶Ǥ Figure6: ͳǡ͵ǡΨ . ǦǢ Ǥ
(110) Ǥ ǡǡDz dzǫȋȌǤ. . ʹ.
(111) DaySurgery____________________________________________________________________________________. StudyV
(112) ǡ Ǥ ȋʹ ȌǤ
(113) ͻǡ Ǥ Table9: αͻͺȋǡ ͳͳǡΨͳȌ PACU Day 1 1 week 16 weeks. Mean VAS / pain % 2.1 3.2 2.0 19 % of patients. ǡͶȀͶͻ ǡ ͵ͻȀͶͻǤǤ ͺ ͵ͷ ȋ͵ȌǤ ͺͺΨǤ ǯ ͳǦǦȋͶͷȌǤ ͳǤ ȋͳͲȌǤ ΨͳͲͲΨ ͳͳǤ ͳǦ Ǥ ǡʹ͵ǡ Ǥ Table 10: QoL VAS score in %. Quality of life VAS score from EQ-5D (1-100) etoricoxib Preoperatively After 16 weeks. ʹͺ . tramadol 88 94. p 92 ns 95 ns.
(114) . ̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴̴. Results. Table11: ȋͲǦͳͲͲΨ Ȍ . . etoricoxib. tramadol. ȋαͶͻȌ. ȋαͶͻȌ. ͳ. ͻͲάͳ͵. ͺάͳ͵. . ʹ. ͺͷάͳ. ͺάͳͺ. αͲǤͲͶͷͶ. ͵. ͺͻάͳ. ͺͲάʹͲ. αͲǤͲͳͶ͵. Ͷ. ͻ͵άͳʹ. ͺάͳ. . ͷ. ͻͶάͳͳ. ͺάͳͻ. αͲǤͲͶʹ. . ͻͶάͳͳ. ͻͲάͳ. . . ͻ͵άͳͶ. ͺͻάͳͻ. . . . . ͻʹǤͲάͳͳǤͺ. ͺͷǤͶάͳͶǤͻ. αͲǤͲͶͲʹ. . . . . ͳͷ. . . . . ͳǤͺάͳǤʹ. ʹǤͷάͳǤ. αͲǤͲͳͺ. ͳǦη͵ Ǧ ȋǤǤȌ. ͳǦ. ns: non-significant difference between study groups. . ʹͻ.
(115) DaySurgery____________________________________________________________________________________. Summary
(116) ǦǤǦ ǡ Ǥ
(117)
(118) ͵ ǡ ǡ Ǥ Ǥ
(119)
(120)
(121) ǡǯǦǦͶ ǡ Ǥ ͶǤ
(122) ǡǦǦǡ Ǧ Ǥ ǡͳǦǡ Ǥ. ͵Ͳ .
Related documents
Där bostadsbebyggelsen ska stå kommer det att bli en hårddjord yta, men det kommer bli mer växtlighet på den resterande ytan, eftersom planbestämmelsen ändras från torg till
2845.. Ett av nedanstående alternativ är det rätta värdet. a) Ange en följd av 10 konsekutiva positiva heltal som inte inne- håller något primtal... b) Visa att för varje
13 kap 10 § - Beslut om förvärv eller överlåtelse av den omyndiges fasta egendom eller nyttjanderätt till sådan egendom ävensom upplåtande av nyttjanderätt, panträtt m.m..
[r]
Inga buskar, träd eller övriga växter med djupgående rötter växer på infiltration Infiltration har ej belastats och belastas ej av fordon, stora djur (kor, hästar), eller
Inga buskar, träd eller övriga växter med djupgående rötter växer på markbädd Markbädd har ej belastats och belastas ej av fordon, stora djur (kor, hästar),
utbildning i svenska för invandrare Rektor SL 20:33 Beslut kan överklagas till Skolväsendets överklagande-
(4p) Man vill jämföra två metoder för mätning av en vis variabel som anses normalfördelad med okänd standardavvikelse. Svar: Eftersom 0 ligger i intervallet kan vi INTE påstå